Meeting
2021 ASCO Annual Meeting
The risk and tropism of central nervous system metastases (CNS) in patients with stage II cutaneous melanoma.
Authors
Paul Johannet
NYU Grossman School of Medicine, New York, NY
Paul Johannet , Min Jae Kim , Melissa Call , Nicholas Gulati , Judy Zhong , Janice M. Mehnert , Iman Osman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9551)
DOI
10.1200/JCO.2021.39.15_suppl.9551
Abstract #
9551
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Effect of more versus less frequent abdominopelvic computed tomography follow-up testing on overall survival in patients with stage II or III colon cancer.
First Author: Jeon Jeongseok
Poster
2022 ASCO Annual Meeting
Plasma methylated DNA markers of cutaneous melanoma: Association with PET/CT-positive disease.
First Author: Alexander Meves
Poster
2022 ASCO Annual Meeting
Analysis of overall survival (OS) and relapse-free-survival (RFS) in the phase 1b clinical trial of anti–PD-1 ab (toripalimab) plus intralesional injection of OrienX010 in stage Ⅳ melanoma with liver metastases.
First Author: Chuanliang Cui
Poster
2021 ASCO Annual Meeting
Incidence, timing, and predictors of CNS metastasis in patients (Pts) with clinically localized cutaneous melanoma (CM).
First Author: Merve Hasanov